Clinical & Pharma

How Are Trump Funding Cuts Impacting UC Medical Research?
Clinical & Pharma How Are Trump Funding Cuts Impacting UC Medical Research?

In the heart of California, where innovation often leads the charge against life-threatening diseases, a chilling uncertainty grips the University of California (UC) medical research community as federal funding, the very lifeline of groundbreaking studies at campuses like UCLA, has been frozen by

Dyslexia Diagnosis Needs Support to Avoid Empty Labels
Clinical & Pharma Dyslexia Diagnosis Needs Support to Avoid Empty Labels

In the realm of education, few topics ignite as much passion and concern as the identification of dyslexia in children, a process that holds the promise of tailored support but often falls short without proper follow-through, leaving many families and educators frustrated. For countless families

Can Geriatrics Training Survive Funding Uncertainty?
Clinical & Pharma Can Geriatrics Training Survive Funding Uncertainty?

I'm thrilled to sit down with James Maitland, a renowned expert in geriatrics and healthcare policy, whose extensive work has shaped innovative approaches to training healthcare providers for an aging population. With a deep understanding of programs like the Geriatrics Workforce Enhancement

How Does Vici Syndrome Link to Parkinson’s Disease?
Clinical & Pharma How Does Vici Syndrome Link to Parkinson’s Disease?

In a remarkable stride forward in medical research, a recent study published in the Annals of Neurology on October 8, 2025, has unveiled a profound genetic connection between Vici syndrome, a rare childhood neurodevelopmental disorder, and Parkinson’s disease, a condition typically associated with

2025 Nobel Prize: Breakthrough in Immune Tolerance Research
Clinical & Pharma 2025 Nobel Prize: Breakthrough in Immune Tolerance Research

In a landmark moment for medical science, the Nobel Prize in Physiology or Medicine has been awarded to Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi for their transformative discoveries in peripheral immune tolerance, a critical mechanism that ensures the immune system safeguards the body

Astellas: Innovating Healthcare with Robust R&D Investment
Clinical & Pharma Astellas: Innovating Healthcare with Robust R&D Investment

In a world where healthcare challenges continue to evolve with staggering complexity, Astellas emerges as a global pharmaceutical leader dedicated to transforming innovative science into tangible solutions for patients across the globe. With a market presence in over 70 countries and operating

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later